Evidence for ineffective erythropoiesis in severe sickle cell disease
about
Oxidative stress in β-thalassaemia and sickle cell diseaseReconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Iron Loading and Overloading due to Ineffective Erythropoiesis.Growth differentiation factor 15 in erythroid health and disease.Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndromeReduction of intramedullary apoptosis after stem cell transplantation in black african variant of pediatric sickle cell anemia.A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis.Alterations in bone and erythropoiesis in hemolytic anemia: comparative study in bled, phenylhydrazine-treated and Plasmodium-infected mice.Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.Association of chromosome damage detected as micronuclei with hematological diseases and micronutrient status.Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.Hematopoietic cell transplantation for sickle cell disease: state of the art.mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease.Mixed chimerism in SCT: conflict or peaceful coexistence?Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.Modulators of erythropoiesis: emerging therapies for hemoglobinopathies and disorders of red cell production.LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis.Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.Transfusion policy: when to stop the use of extremely rare blood for an allogeneic hematopoietic progenitor cell transplant recipient with a history of red cell alloimmunization.Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells.Peripheral red blood cell split chimerism as a consequence of intramedullary selective apoptosis of recipient red blood cells in a case of sickle cell disease.Stem cell transplantation after reduced-intensity conditioning for sickle cell disease.Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia.In mixed hematopoietic chimerism, the donor red cells win.Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies.Effect of Trypanosoma brucei brucei on erythropoiesis in infected rats.Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease.Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.Hemosiderosis causing liver cirrhosis in a patient with Hb S/beta thalassemia and no other known causes of hepatic disease.
P2860
Q26797178-9B93A4ED-E684-4C37-9BF6-6183AC26440BQ33803027-13F38EC2-C33D-481A-B3DF-9117553392C1Q33844026-27144F1E-5988-49D0-A02F-18323F0532B9Q33908936-AA3FC619-DF22-4294-886B-E332B56A29F3Q33910479-90E40A63-F71F-4565-A3B8-5EABB524392CQ33920142-34B70DB4-A892-432E-A792-B552509980F8Q34038874-8E83C8CF-19E7-4D5D-89BF-77FF5DAB911AQ34430802-8C81ABAA-F369-4A74-AB54-FF8B70FF22FAQ34451588-F6AEC771-3837-4F22-B4F7-8D14C153BC2FQ35022988-1FFDA1B0-32AF-4A59-8559-CF229089E2BAQ36548358-33492B1A-C17E-4EBD-88B0-00FE35D5CE98Q36596865-21729C51-2800-486D-B891-BA2908B6D59DQ36717337-4F9DB9C3-D86F-435E-B6EE-61777ADB40CDQ37123996-638FC235-34C9-400D-9EE2-C5925AB039B8Q37228383-ED743893-4802-4301-A093-8B2141714792Q37344320-BA1A665B-E8C5-45C3-B7FB-D83739D90659Q37673351-7AB2F8C0-E5FB-4A22-8884-1998A3F0B810Q38349410-2EF412D3-B048-48D9-90EC-3D7FBC0AC13FQ38982997-0E725AA7-13BE-4DCD-AA7D-D0B3953D446BQ40218366-6B7D5792-53E1-4BE1-B06E-2685EA51330DQ40412263-AF12E9DE-8D79-4736-B95A-034BD6A47076Q42106466-AD4FF4A2-505B-4BB8-960F-B765648F7995Q42276884-416BC021-13B4-4C81-9F8B-7F53C2B2E830Q42365049-240ECAFC-276A-49AF-8F83-35D2FF7E8DE9Q42558435-DB6E94C7-93AB-423E-B75C-9C56E90BD4D2Q42724208-23906B34-0987-42EB-8F98-799234B84A3EQ46752015-BA8C6773-B904-4DEB-A5E5-35CA8E2A4381Q46865136-F0D251CA-D283-4DFC-9650-F36557FA23BBQ47614537-08D9310E-B93A-41F8-B51A-129010327049Q55190097-0D4C83C2-9D50-4FEC-A99A-706F9D7C8352
P2860
Evidence for ineffective erythropoiesis in severe sickle cell disease
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Evidence for ineffective erythropoiesis in severe sickle cell disease
@ast
Evidence for ineffective erythropoiesis in severe sickle cell disease
@en
type
label
Evidence for ineffective erythropoiesis in severe sickle cell disease
@ast
Evidence for ineffective erythropoiesis in severe sickle cell disease
@en
prefLabel
Evidence for ineffective erythropoiesis in severe sickle cell disease
@ast
Evidence for ineffective erythropoiesis in severe sickle cell disease
@en
P2093
P2860
P1433
P1476
Evidence for ineffective erythropoiesis in severe sickle cell disease
@en
P2093
Catherine J Wu
Jeffery L Kutok
Jerome Ritz
Joseph H Antin
Lakshamanan Krishnamurti
Melinda Biernacki
Shelby Rogers
Wandi Zhang
P2860
P304
P356
10.1182/BLOOD-2005-04-1376
P407
P577
2005-08-09T00:00:00Z